Maintenance Therapy With Lenalidomide Following Bendamustine and Rituximab Induction Therapy for Chronic Lymphocytic Leukemia
Phase of Trial: Phase II
Latest Information Update: 28 Nov 2014
At a glance
- Drugs Lenalidomide (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Therapeutic Use
- 12 Jun 2014 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov record.
- 05 Mar 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 25 Jan 2012 Planned End Date changed from 1 Jul 2016 to 1 Mar 2016 as reported by ClinicalTrials.gov.